MedMatch is currently in Beta and we’re starting with customers seeking support for anxiety and depression on the Hims & Hers platform, because of the clear evidence that the U.S. is experiencing a mental health crisis. Many people avoid seeking treatment due to stigma and lack of education for psychiatric disorders – and if they do take the leap to seek treatment, there is often a shortage of mental health professionals. If a patient is able to find a provider and receive treatment, it can require multiple visits, too much time and too much money, and treatment is typically based on their provider’s experience, rather than the full picture of their own experience.
MedMatch is being continuously developed to help providers on the platform identify the optimal treatment for a particular person, which can include the most appropriate treatment formulation to dosage strength to form factor. Trained on anonymized historical clinical visits, demographics, treatment types, and patient outcomes, MedMatch has the unique ability to recommend clinical decisions and treatments supported and informed by the collective knowledge of thousands of providers and millions of data points.
In this initial Beta phase, we’re evaluating MedMatch on independent metrics, like remission rates once treatment begins, time to remission, and patient satisfaction. As MedMatch continues to develop, we’ll implement it across all of our categories with trained models, so more of our customers can experience truly personalized care that they can trust.
At Hims & Hers, we’re working to help everyone feel great through the power of better health. That starts with using technology to unmatched clinical care, and we believe connecting the right patient with the right personalized treatment will result in better clinical outcomes and greater likelihood of long-term patient happiness.
You can learn more about MedMatch and how it is creating a new standard of care here.
